CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 9, 2022 · earnings

BTAI earnings: a negative outcome, -9.6%

On May 9, 2022, BioXcel Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -9.6% in the window around the event. It had already run -26.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$200.96
1d before
$181.76
Event day
$179.68
1d after
$187.84
5d after

Pre-catalyst setup

-26.6%
30-day run-up
7345%
30-day volatility
0.4×
volume spike